CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products for comparison (0)
Companies for comparison (0)
Compare (0)
Login
Upgrade
My profile

My favorites

My events & webinars

Company profiles

Leads & Statistics

CPHI Online Home
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Upgrade

News

8 Apr 2011

Analyst: J&J May Need A $10B-plus Deal

The company may look at deals worth more than $10 billion to compensate for a lack of organic growth and to provide an outlet for its steady buildup of cash.

In a note to investors, Morgan Stanley's David Lewis says Johnson & Johnson may be looking at consumer deals outside the U.S., along with buys in medical devices and diagnostics. And as Bloomberg points out, the company had a $27.7 billion stash of cash and short-term investments at the end of 2010--ample capital for a shopping foray.

Related News

News Abortion pills can now be sold in retail pharmacies according to the US FDA

In the US, retail pharmacies will be allowed to sell abortion pills for the first time, after latest approval is granted by the FDA.

5 Jan 2023
News Moderna to buy OriCiro Genomics in USD $85 million deal

Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio.

5 Jan 2023
News New year, new prices: at least 350 drugs in USA to see price increases in January

Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January.

3 Jan 2023
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0

Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.

2 Jan 2023
News CPHI Frankfurt: Interview with Marcelo Cruz, Vice President, Business Development & Marketing at Tjoapack

In this series of interviews, we caught up with some of the exhibitors at CPHI Frankfurt to discover what innovations are being brought to the pharmaceutical industry this year. Here we chat with Marcelo Cruz of Tjoapack to discuss how global events ar...

23 Dec 2022
News Strategic partnership between AstraZeneca and G42 Healthcare to increase pharmaceutical manufacturing in Abu Dhabi

A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country.

21 Dec 2022
News Trend Report: The True Cost of API Price Rises

Download our Trend Report to discover what the current landscape of APIs and their pricing means for the pharmaceutical industry in the future.

5 Dec 2022
News Alzheimer's drug lecanemab shows reduced cognitive decline in clinical trial

A monoclonal antibody drug, named lecanemab, has been tested in a Phase III clinical trial in nearly 1800 participants, with promising results in reducing the effects of Alzheimer's disease on the brain.

1 Dec 2022